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RESEARCH
Aggressive re-warming at 38.5 °C 
following deep hypothermia at 21 °C increases 
neutrophil membrane bound elastase activity 
and pro-inflammatory factor release
Min Tang1*, Xiao‑gang Zhao2, Yi He1, John Yan Gu3 and Ju Mei1*
Abstract 
Background: Cardiopulmonary bypass (CPB) is often performed under hypothermic condition. The effects of 
hypothermia and re‑warming on neutrophil activity are unclear. This study aimed to compare the effects of different 
hypothermia and re‑warming regimens on neutrophil membrane bound elastase (MBE) activity and the release of 
pro‑inflammatory factors from neutrophils.
Methods: Human neutrophils were exposed to different hypothermia and re‑warming regimens. MBE activity and 
the release of interleukin (IL)‑β1, IL‑6, IL‑8, and tumor necrosis factor (TNF)‑α were measured.
Results: Neutrophil MBE activity was significantly reduced after 60‑min moderate (28 °C) or deep (21 °C) hypother‑
mic treatment. Compared with normothermic (37 °C) re‑warming, aggressive re‑warming (38.5°) for 120 min follow‑
ing deep hypothermia (21 °C) dramatically increased neutrophil MBE activity (P < 0.05). Co‑incubation of neutrophils 
with platelet‑rich plasma further increased MBE activity significantly under all the tested temperature regimens. IL‑β1 
release from neutrophils was significantly higher after deep hypothermia (21 °C) followed by normothermic (37 °C) 
re‑warming than after moderate hypothermia (28 °C) followed by normothermic re‑warming (P < 0.05). Aggressive re‑
warming (38.5°) following deep hypothermia significantly increased the release of IL‑β1, IL‑8, and TNF‑α from neutro‑
phil compared with moderate re‑warming (37 °C) (all P < 0.05).
Conclusion: Aggressive re‑warming following deep hypothermia may contribute to CPB‑associated tissue injury 
by increasing neutrophil MBE activity and stimulating pro‑inflammatory factor release, thus, should be avoided. The 
optimal hypothermic temperature of CPB should be determined based on patient clinical characteristics and surgery 
type.
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Background
Cardiopulmonary bypass (CPB), a common procedure 
used in cardiac and thoracic surgery, is usually per-
formed under hypothermia to reduce the body’s meta-
bolic rate and decrease oxygen consumption so to protect 
organs, such as the brain, kidneys, lungs, and heart from 
ischemic injuries. Despite the hypothermic approach, 
CPB still cause adverse systemic inflammatory responses, 
consequently leading to postoperative morbidity and 
mortality (Liguori et al. 2014). In addition to those well-
known reasons causing CPB-induced adverse systemic 
inflammation, such as the contact of blood with the arti-
ficial surface of a CPB circuit and ischemia–reperfusion 
during CPB, the re-warming process during re-perfusion 
after CPB might also be a contributing factor.
Currently, several hypothermia and re-warming regi-
mens have been used in CPB (Grigore et al. 2009). Deep 
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hypothermic circulatory arrest is often practiced for 
complex cardiothoracic surgeries, such as aortic surgery 
and repair of complex congenital defects, to create a 
bloodless surgical field and protect brain function (Lima 
et al. 2011). It has been shown that hypothermia during 
CPB exerts significant brain protection, suppresses the 
release of free radicals, and inhibits destructive enzy-
matic reactions (Hicks et  al. 2000; Yager and Asselin 
1996; Bernard et al. 2002; Safar and Kochanek 2002; Safar 
2003). Different re-warming temperatures have also been 
tested. In addition to normothermic re-warming at 37 °C, 
aggressive re-warming at a higher temperature such as 
38.5 °C has also been considered because it can consider-
ably reduce the duration of CPB (Hata et al. 2009). How-
ever, Grigore et  al. (2001, 2002) found that aggressive 
re-warming was significantly associated with poor neuro-
cognitive outcomes. In addition, hyperthermic perfusion 
is discouraged in the current American guidelines for 
CPB management because of the risk of neurologic com-
plications (Engelman et al. 2015). Although the impact of 
temperature regimens of CPB on neurologic function has 
been extensively studied, the effects of hypothermia and 
re-warming regimen on inflammatory responses remain 
unknown.
Activation of neutrophils is considered as one of the 
key mechanisms underlying CPB-induced inflamma-
tion (Butler et al. 1993). During CPB, neutrophils can be 
stimulated to secrete lactoferrin and elastase (Colman 
1990), and the stimulated neutrophils have been found 
to release pro-inflammatory factor IL-8 (Altstaedt et  al. 
1996), leading to adverse systemic inflammation. The 
purpose of this study was to investigate the effects of dif-
ferent hypothermia and re-warming regimens on neu-
trophil activation in  vitro by measuring the activity of 
neutrophil membrane bound elastase (MBE), which is 
considered as an inflammation indicator. The effects of 
different temperature regimens on pro-inflammatory fac-
tor release from neutrophils were also studied.
Methods
Blood sample collection
The study protocol was approved by the Institutional 
Review Board of Shanghai Xinhua hospital. Signed 
informed consent was obtained from each blood donor. 
Blood samples were collected from 15 healthy men at 
Shanghai Xinhua Hospital. A total of 20 mL whole blood 
was withdrawn from each donor and mixed immediately 
with 0.3 mL sterilized anticoagulant solution containing 
10  % (w/v) ethylene diamine tetraacetic acid in phos-
phate-buffered saline (PBS). To prevent bacterial contam-
ination, all the laboratory supplies used in the study were 
sterilized.
Neutrophil isolation
Neutrophil isolation was performed according to the pre-
vious description (Hjorth et al. 1981). Briefly, the freshly 
collected whole blood samples were centrifuged at 160×g 
for 10 min at 4  °C. The plasma layer was then collected 
and diluted with PBS at 1:1 (v/v) ratio. A buffer for dis-
continuous gradient centrifugation was prepared by 
overlaying 4 mL of 55 % (v/v) Percoll (Sigma®, St. Louis, 
MI, USA) in 0.9  % (w/v) NaCl solution (ρ  =  1.1026  g/
mL) on top of 4 mL of 74 % Percoll in 0.9 % NaCl solution 
(ρ = 1.0776 g/mL). Four mL of plasma concentrate was 
subsequently overlaid on top of the gradient buffer and 
centrifuged at 350×g for 20 min at 4 °C. The neutrophil 
band, which was the layer between the 2 layers of Per-
coll, was carefully removed using a Pasteur pipette. The 
collected neutrophils were washed with PBS and cen-
trifuged at 350×g for 15 min at 4  °C. The contaminated 
red blood cells in the neutrophil collection were removed 
by incubating the neutrophil with hypotonic lysis buffer 
(0.83 % w/v, NH4Cl, 0.0037 % w/v, Na2EDTA, 0.1 % w/v 
KHCO3) for 5  min at room temperature. Neutrophils 
were collected and washed by centrifugation at 160×g 
for 5 min. The purity and viability, which was determined 
by Giemsa stain and trypan blue (0.01 % w/v) exclusion, 
respectively, were all >95  %. Neutrophils were counted 
using a haemocytometer under a microscope, and diluted 
in PBS to a final concentration of 4 ×  106  cells/mL for 
future experiments.
Platelet‑rich plasma (PRP) preparation
Ten mL of plasma obtained by centrifugation of whole 
blood at 160×g for 10  min at 4  °C was further centri-
fuged at 350×g for 10 min at 4  °C. After centrifugation, 
1 mL solution was removed from the bottom of the tube, 
which was considered as PRP. The 1 mL PRP was mixed 
with 20 μL sterile water containing 300 IU thrombin and 
incubated at 37 °C for 10 min. The final concentration of 
thrombin in PRP was 0.25 IU/mL.
Hypothermic and re‑warming treatment for neutrophils
The protocol of hypothermia and re-warming is illus-
trated in Fig.  1. Neutrophils were aliquoted and treated 
with 4 different temperature regimens, respectively. For 
moderate hypothermia followed by normothermic re-
warming treatment (28–37  °C), neutrophils were incu-
bated at 37 °C for 30 min, 28 °C for 60 min, and then 37 °C 
for 120  min. In deep hypothermia followed by normo-
thermic re-warming treatment (21–37  °C), neutrophils 
were incubated at 37 °C for 30 min, 21 °C for 60 min, and 
then 37  °C for 120 min. For deep hypothermia followed 
by aggressive re-warming treatment (21–38.5  °C), neu-
trophils were incubated at 37  °C for 30  min, 21  °C for 
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60 min, and then 38.5 °C for 120 min. In the control treat-
ment, neutrophils were incubated at 37  °C for 210 min. 
Neutrophils were incubated with either PBS or PRP in 
each temperature treatment. Thermocycler (Gene Amp® 
2400, Applied Biosystem, USA) for polymerase chain 
reaction was used for the hypothermia and re-warming 
treatments according to our previous description (Tang 
et  al. 2004, 2010). Aliquots of 50 μL neutrophil suspen-
sion either in PBS or mixed with PRP was prepared. The 
aliquots were treated with the four specific hypothermia 
and re-warming regimens, respectively. The thermocy-
cler was pre-heated to 37  °C. The hypothermia and re-
warming protocols were programmed before neutrophil 
samples were placed into the thermocycler. At each spe-
cific time point for MBE measurement, the correspond-
ing neutrophil aliquots was quickly removed from the 
thermocycler and measured for MBE activity immedi-
ately. Three aliquots were used for each measurement.
Determination of membrane‑bound elastase (MBE) activity
MBE activity was measured at baseline (T0) and the fol-
lowing specific time points: T1: at the end of the hypo-
thermia, T2: 30 min after re-warming, T3: 60 min after 
re-warming, T4: 90  min after re-warming, and T5: 
120 min after re-warming. When neutrophils were incu-
bated with PRP, MBE activity was only measured at 120-
min re-warming (Fig.  1). MBE activity was measured 
according to the method described previously (Owen 
et al. 1995). Briefly, after temperature treatments, neutro-
phils were collected by centrifugation at 160×g at 25  °C 
for 5  min, fixed by paraformaldehyde (3  % w/v in PBS) 
and glutaraldehyde (1  % v/v in PBS, both from Sigma®, 
St. Louis, MI, USA) at 4  °C for 3 min, and then washed 
twice in PBS by centrifugation at 160×g at 4  °C for 
15 min. The neutrophils were then re-suspended in PBS 
and MBE activity was analyzed by a substrate method. A 
50  μL aliquot of neutrophil suspension was mixed with 
150  μL of substrate solution containing 1  mM N-succi-
nyl-(l-alanine)3-p-nitroanilide (Sigma®, St. Louis, MI, 
USA) dissolved in 200  mM Tris–HCl (pH 8.0), and the 
mixture was incubated at 37  °C for 60  min. The reac-
tion was terminated by adding 5 μL of glacial acetic acid. 
Absorbance at 405  nm was recorded in a Bio-Rad plate 
reader (Bio-Rad®, Hercules, USA). A standard curve of 
elastase was prepared using different concentrations of 
standard elastase solution (Sigma®, St. Louis, MI, USA) 
in the substrate solution. MBE activity was expressed as 
ng enzyme/106 neutrophils. The sensitivity of this assay 
was 0.5 ng enzyme/106 neutrophils.
ELISA analysis of pro‑inflammatory factors
Neutrophils from each volunteer were treated with the 
4 temperature regimens, respectively. At the end of each 
treatment, IL-β1, IL-6, IL-8, and TNF-α in the culture 
supernatants were analyzed by ELISA using a kit accord-
ing to the protocol provided by the manufacturer (R&D 
System, USA).
Statistical analysis
The statistical analysis was performed using the soft-
ware SPSS 19.0. Data are presented as mean ± standard 
deviation. One-way ANOVA was used to compare MBE 
activity and inflammatory factor levels among different 
groups. P value was 2-sided and P < 0.05 was considered 
significantly different.
Results
Deep hypothermia followed by aggressive re‑warming 
increased neutrophil MBE activity the most
MBE activity was reduced significantly after 60-min 
hypothermia (P < 0.05) compared with the baseline val-
ues, and the reduction was similar after moderate (28 °C) 
or deep (21  °C) hypothermia (8.6  ±  4.3  ng/106  cells 
vs. 10.5  ±  9.1  ng/106, P  =  0.837, Fig.  2). MBE activity 
remained at significant low levels after 30-min re-warm-
ing at 37  °C or 38.5  °C. At 60-min re-warming, MBE 
activity was significantly higher in neutrophils treated 
with aggressive re-warming (38.5  °C) than in neutro-
phils treated with normothermic re-warming (37  °C) 
(P  <  0.05). At 120-min re-warming, MBE activity of 
neutrophils treated with deep hypothermia followed by 
normothermic re-warming (21–37  °C) was at the simi-
lar level to the baseline value (35.2  ±  17.0  ng/106  cells 
vs. 26.2 ± 11.4 ng/106 cells, P > 0.05). In contrast, both 
deep hypothermia followed by aggressive re-warming 
(21–38.5  °C) and moderate hypothermia followed by 
normothermic re-warming (28–37  °C) increased MBE 
activity significantly compared with the baseline values 
37°C Hypothermia at 28°C or 21°C Re-warming at 37°C or 38.5°C
30 min 60 min 120 min
Baseline T0 T1 60 min T2 30 min T3 60 min T4 90 min T5 120 min
Fig. 1 Protocol of hypothermia and re‑warming and time point of MBE measurement
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(70.6 ± 10.5 ng/106 cells vs. 27.2 ± 10.2 ng/106 cells and 
50.2  ±  10.1  ng/106  cells vs. 29.7  ±  11.6  ng/106  cells, 
respectively, all P  <  0.05, Fig.  2) at the end of 120-min 
re-warming. MBE activity under the control treat-
ment increased continuously through the experiment, 
and reached the highest 2  h after incubation at 37  °C 
(74.3 ± 5.1 ng/106), which was similar to the MBE activ-
ity 2 h after aggressive re-warming (70.6 ±  10.5 ng/106, 
P > 0.05). Co-incubation of neutrophils with PRP during 
the temperature treatments significantly increased MBE 
activity compared with neutrophil alone for all the tem-
perature regimens (all P < 0.05, Fig. 3).
Aggressive re‑warming increased the release 
of pro‑inflammatory factors from neutrophils
ELISA assay on pro-inflammatory factor secretion 
showed that deep hypothermia followed by aggressive 
re-warming regimen (21–38.5 °C) significantly increased 
the release of IL-β1, IL-8, and TNF-α from neutrophils 
compared with moderate hypothermia followed by nor-
mothermic re-warming regimen (28–37 °C) (All P < 0.05, 
Fig.  4). Deep hypothermia followed by normothermic 
re-warming regimen (21–37  °C) increased IL-β1 release 
from neutrophils significantly compared with moder-
ate hypothermia followed by normothermic re-warming 
(28–37  °C) (3.95  ±  0.236  ng/L vs. 3.26  ±  0.253  ng/L, 
P < 0.05, Fig. 4).
Discussion
In this current study, both moderate (28  °C) and deep 
hypothermia (21  °C) significantly decreased neutrophil 
MBE activity in  vitro. Interestingly, deep hypothermia 
followed by normothermic re-warming (21°–37 °C) kept 
neutrophil MBE activity at a lower or similar level to the 
baseline value. In contrast, moderate hypothermia fol-
lowed by normothermic re-warming (28°–37 °C) resulted 
in a fast increase in neutrophil MBE activity after 60-min 
re-warming, and the MBE activity at the end of 2  h of 
re-warming was about 1.7 folds of the baseline value. 
In vivo studies showed similar results. Significantly lower 
elastase activity has also been observed in the blood 
Fig. 2 Neutrophil MBE activity at different time point of tempera‑
ture regimens. Neutrophils were treated with the four temperature 
regimens, respectively. MBE activity was then measure at the specific 
time point. Average MBE activity was calculated, n = 15. Values were 
compared using one‑way ANOVA. *Significant difference between 
the indicated values and the baseline values of the respective 
temperature regimen. #Significant difference between aggressive re‑
warming (38.5 °C) and normothermic re‑warming (37 °C). P < 0.05
Fig. 3 Co‑incubation with PRP further increased neutrophil MBE 
activity. Neutrophils were co‑incubated with PRP during different 
temperature treatments. MBE activity was measure at 120‑min re‑
warming. MBE activity was compared between the co‑incubation 
of neutrophils with PRP and the neutrophils alone. Comparison was 
analyzed by Student’s t test. *Significant difference between co‑
incubation with PRP and neutrophil alone, P < 0.05
Fig. 4 Aggressive re‑warming followed by deep hypothermia 
significantly increased the release of pro‑inflammatory factors. 
Neutrophils were treated with different temperature regimens. The 
concentrations of IL‑β1, IL‑6, IL‑8, and TNF‑α in the incubation media 
were measured at 120‑min re‑warming by ELISA. Comparison was 
analyzed by one‑way ANOVA. *Significant difference between the 
indicated groups, P < 0.05
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samples of patients undergoing cold (26.3 ± 0.5 °C) CPB 
compared with warm (31.8  ±  0.4  °C) CPB (Menasché 
et  al. 1995). Elevation of neutrophil elastase is associ-
ated with CPB-induced tissue damage and inflammation 
(Kawabata et al. 2002; Shapiro 2002). Thus, these results 
suggest that CPB at a low temperature may reduce CPB-
associated tissue damage and inflammation by keeping 
neutrophil elastase activity at low levels. A continuous 
increase in neutrophil MBE activity in the control treat-
ment (continuous 37  °C) suggests that neutrophils may 
be constantly activated at 37 °C, further supporting that 
hypothermic treatment during CPB may reduce CPB-
associated organ damage. On the other hand, this current 
study also showed that hypothermia at low temperature 
(21  °C) significantly increased the release of the pro-
inflammatory factor IL-β1 from neutrophils compared 
with moderate hypothermic temperature (28  °C). The 
effects of hypothermia on neutrophil elastase activity and 
pro-inflammatory factor release appear to be opposite. 
Thus, the optimal hypothermic temperature of CPB may 
not be the lower the better and should be determined 
based on patient clinical characteristics. Clinical stud-
ies also showed complex effects of hypothermic CPB on 
patient outcome.
Lima et al. (2011) retrospectively reviewed 245 patients 
undergoing proximal arch replacement with deep hypo-
thermic circulation arrest at 18.0  ±  2.1  °C and found 
that both neurologic and non-neurologic outcomes 
were excellent in these patients. The results of this cur-
rent in  vitro study indicate that the beneficial effects of 
deep hypothermia could be mediated by inhibition of 
neutrophil MBE activity. However, deep hypothermic 
CPB might have potential adverse consequences, such 
as an increased risk of postoperative bleeding (Har-
rington et  al. 2004). In addition, deep hypothermia will 
also increase the duration of CPB, which consequently 
will deteriorate CPB-induced inflammation and tissue 
injury. Reich et al. (1999) reported that in senior patients, 
deep hypothermia was associated with memory and find 
motor deficits and prolonged hospital stay. Thus, the 
optimal hypothermic temperature during CPB should be 
determined based on the type of surgery and the clinical 
characteristics of patients.
This current study showed that during the first 30 min 
of the re-warming, neutrophil MBE activity remained 
at low levels and was similar in the normothermic and 
the hyperthermic re-warming groups. This result indi-
cates that neutrophils may need a minimum of 30  min 
to recover from the 2-h hypothermic treatment although 
the temperature of the neutrophils may reach the re-
warming temperature rapidly. After the recovery period, 
the response of neutrophils to normothermia and 
hyperthermia was different. Hyperthermic re-warming 
increased neutrophil MBE activity at higher extent than 
normothermic re-warming. MBE activity was increased 
quickly and dramatically during aggressive hyperther-
mic re-warming (38.5  °C) and reached approximately 
threefolds of the baseline value after 2 h of re-warming at 
38.5 °C. These findings suggest that fast re-warming dur-
ing CPB may cause excessive neutrophil activation and 
exacerbate systemic inflammation.
Additionally, this current study also demonstrated 
that aggressive re-warming following deep hypothermia 
(21–38.5  °C) significantly increased the release of pro-
inflammatory factors, IL-β1, IL-8, and TNF-α compared 
with the moderate temperature treatment (28–37  °C). 
TNF-α has been well recognized to contribute to CPB-
induced systemic inflammation and tissue damage (Hill 
1998). These findings suggest that aggressive re-warming 
following deep hypothermia in CPB not only can dramat-
ically increase neutrophil elastase activity but also can 
stimulate the release of pro-inflammatory factors, conse-
quently leading to tissue damage and systemic inflamma-
tion. Clinical and preclinical studies also demonstrated 
that adverse effects were associated with fast re-warm-
ing. Newman et  al. (1995) found that fast re-warming 
contribute significantly to the decline in complex spatial 
and figure memory of elderly patients undergoing car-
diac surgery. Grigore et al. (2001, 2002) also showed that 
fast re-warming was significantly associated with poor 
postoperative neurocognitive outcomes . In addition, in 
a swine model of lethal hemorrhage, Alam et  al. (2006) 
demonstrated that fast re-warming from deep hypo-
thermia reduced the animal survival substantially com-
pared with medium rate of re-warming. Thus, aggressive 
rewarming following deep hypothermia in CPB should 
be avoided.
Compared with the other temperature treatment, neu-
trophil MBE activity was the highest at the end of the 
continuous 37 °C treatment, whereas the pro-inflamma-
tory factor release at 37 °C treatment was similar to that 
in the normothermic re-warming group. These results 
suggest that neutrophil MBE activity may be elevated 
under continuous 37 °C treatment but pro-inflammatory 
factor release may not. Thus, different molecular and 
cellular mechanisms appear to be involved in the stimu-
lation of MBE activity and the induction of pro-inflam-
matory factor release in neutrophils.
In addition to re-warming, other pro-inflammatory 
factors can further activate neutrophils. In this current 
study, we found that co-incubation with PRP signifi-
cantly further increased MBE activity in all temperature 
regimens. These results indicated that anti-inflamma-
tion therapies in addition to hypothermia, such as 
steroids, are required to effectively prevent or reduce 
CPB-induced inflammatory responses. The neutrophil 
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elastase inhibitor, sivelestat sodium hydrate, has been 
shown to reduce the serum levels of pro-inflammatory 
cytokines IL-6 and IL-8 and attenuate pulmonary dys-
function in patients undergoing CPB (Fujii et  al. 2010; 
Kohira et al. 2013).
In this current in vitro model, although the temperature 
change of neutrophils during hypothermia and re-warm-
ing is much faster than that of the human body exposed 
to CPB, this in  vitro model mimics the temperature 
change of blood in a CPB machine. In a CPB machine, 
the re-warming process is started after the water tank of 
the CPB machine reaches the programmed re-warming 
temperature, and during the phase of re-warming, the 
hypothermic blood in the CPB tube encounter the re-
warming temperature. This in vitro model may be used to 
optimize the hypothermic and re-warming temperature 
regimen in CPB.
Conclusion
The findings of this current study suggest that aggressive 
re-warming following deep hypothermia may contribute 
to CPB-induced tissue injury and systemic inflamma-
tion by increasing neutrophil MBE activity and stimu-
lating pro-inflammatory factor release. Thus, aggressive 
re-warming in CPB should be avoided and the optimal 
hypothermic temperature of CPB should be determined 
based on patient clinical characteristics and surgery type.
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